Tevogen Bio Holdings Inc.TVGNNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | -188.87% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | -192.03% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | -181.38% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +7.63% | +10.03% | +17.53% | +19.55% | +15.19% |
| Weighted Average Shares Diluted Growth | +7.63% | +10.03% | +13.36% | +19.55% | +15.19% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -32.60% | -37.12% | +21.10% | +28.97% | +4.76% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -96.83% | -96.98% | +132.00% | +274.71% | +153.98% |
| R&D Expense Growth | +191.96% | +212.35% | -84.65% | -34.54% | -4.61% |
| SG&A Expenses Growth | +144.31% | +542.11% | -18.95% | -43.91% | -4.83% |